ImmuPharma (LSE:IMM) OCF Margin %: 0.00% (As of Dec. 2025)


What is ImmuPharma OCF Margin %?

ImmuPharma LSE:IMM -6.80% OCF Margin % is 0.00% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 959 Biotechnology companies, ImmuPharma ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. ImmuPharma's Cash Flow from Operations for the six months ended in Dec. 2025 was £-1.37 Mil. ImmuPharma's Revenue for the six months ended in Dec. 2025 was £0.00 Mil. Therefore, ImmuPharma's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, ImmuPharma's current OCF Yield % is -8.63%.

The historical rank and industry rank for ImmuPharma's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of ImmuPharma was -2621.26%. The lowest was -5828.40%. And the median was -4013.34%.

LSE:IMM's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

ImmuPharma OCF Margin % Related Terms

ImmuPharma OCF Margin % Historical Data

* Premium members only.

The historical data trend for ImmuPharma's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmuPharma OCF Margin % Chart

ImmuPharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,095.76 0.00 0.00 0.00 0.00

ImmuPharma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,015.71 0.00 0.00 0.00 0.00

ImmuPharma OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

ImmuPharma's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-2.372/0
= %

ImmuPharma's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.367/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
ImmuPharma (LSE:IMM) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ImmuPharma and its competitors. According to the industry distribution chart, ImmuPharma ranks #999999 out of 959 companies in the Biotechnology industry.
Is ImmuPharma's OCF Margin % too high?
ImmuPharma's current OCF Margin % is 0.00%. Based on the distribution chart, ImmuPharma ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does ImmuPharma's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ImmuPharma ranks #999999 out of 959 companies for OCF Margin %. This places ImmuPharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ImmuPharma and its competitors. ImmuPharma's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ImmuPharma stock overvalued right now?
ImmuPharma (LSE:IMM) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For ImmuPharma (LSE:IMM), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ImmuPharma Business Description

Other Exchanges IMMl:UK25I:Germany
Address One Bartholomew Close, London, GBR, EC1A 7BL
ImmuPharma PLC focuses on the research, development, and commercialisation of pioneering and novel drugs in specialist therapeutic areas within the pharmaceutical industry. The company's pipeline products are P140, CDx, Kapiglucagon, BioAMB, and BioCIN.